Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Osimertinib is a third-generation EGFR-TKI-targeted drug, and its clinical application needs to strictly follow the dosage specifications and medication precautions to ensure the t···【more】
Article source：Captain MedicineRelease date：2025-03-04Recommended：275
Explore osimertinib and its role in the treatment of lung cancer, as well as its side effect management.What are the indications for osimertinibTo understand osimertinib in depth, ···【more】
Article source：Captain MedicineRelease date：2025-02-28Recommended：208
Explore the price of osimertinib and its role in treatment, as well as learn how to better manage the associated costs.Is osimertinib expensive? How much is a box?Osimertinib has a···【more】
Article source：Captain MedicineRelease date：2025-02-28Recommended：215
Osimertinib latest price in 2025Understanding how the price of osimertinib will change in 2025 is important for patients and their families who require this medication.Price differ···【more】
Article source：Captain MedicineRelease date：2025-02-27Recommended：200
How much is osimertinib a boxExploring the price of osimertinib is crucial for patients who need this drug.Price fluctuations and regional differencesThe price of osimertinib varie···【more】
Article source：Captain MedicineRelease date：2025-02-27Recommended：189
Cabozantinib is a multi-kinase inhibitor that is often used in combination with other drugs in clinical treatment, but its interaction with other drugs is a cause for concern.What ···【more】
Article source：Captain MedicineRelease date：2025-02-26Recommended：215
Cabozantinib is a multi-targeted tyrosine kinase inhibitor that has been widely used in the treatment of a variety of tumors in clinical practice. However, its interactions with ot···【more】
Article source：Captain MedicineRelease date：2025-02-25Recommended：236
Cabozantinib is a multi-targeted tyrosine kinase inhibitor that plays an important role in cancer therapy. However, its use also comes with a series of caveats. This article will d···【more】
Article source：Captain MedicineRelease date：2025-02-25Recommended：237
Cabozantinib is a multi-kinase inhibitor that has shown significant efficacy in the treatment of a variety of tumors, but its use comes with a number of caveats.What are the precau···【more】
Article source：Captain MedicineRelease date：2025-02-24Recommended：283
Cabozantinib is a multi-targeted tyrosine kinase inhibitor, and special attention should be paid to the details of its use and potential impact in clinical applications.What are th···【more】
Article source：Captain MedicineRelease date：2025-02-24Recommended：224
Cabozantinib is a widely used drug for the treatment of a variety of cancers, and its side effects are of great concern.Does cabozantinib have side effectsExploring the side effect···【more】
Article source：Captain MedicineRelease date：2025-02-21Recommended：196
Cabozantinib is a multi-targeted tyrosine kinase inhibitor that has demonstrated significant efficacy in a variety of cancer treatments. However, its accompanying side effects have···【more】
Article source：Captain MedicineRelease date：2025-02-21Recommended：243
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：1702025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4092024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：1662025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：1852025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：1642025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2002025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：1812025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：1732025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
